CA2533136A1 - Traitement de lesions cerebrales perinatales hypoxiques-ischemiques - Google Patents

Traitement de lesions cerebrales perinatales hypoxiques-ischemiques Download PDF

Info

Publication number
CA2533136A1
CA2533136A1 CA002533136A CA2533136A CA2533136A1 CA 2533136 A1 CA2533136 A1 CA 2533136A1 CA 002533136 A CA002533136 A CA 002533136A CA 2533136 A CA2533136 A CA 2533136A CA 2533136 A1 CA2533136 A1 CA 2533136A1
Authority
CA
Canada
Prior art keywords
bodies
phosphate
liposomes
glycerol
perinatal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002533136A
Other languages
English (en)
Inventor
Charles Palmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vasogen Ireland Ltd
Original Assignee
Vasogen Ireland Limited
Charles Palmer
The Penn State Research Foundation
Vasogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vasogen Ireland Limited, Charles Palmer, The Penn State Research Foundation, Vasogen, Inc. filed Critical Vasogen Ireland Limited
Publication of CA2533136A1 publication Critical patent/CA2533136A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002533136A 2003-07-21 2004-07-20 Traitement de lesions cerebrales perinatales hypoxiques-ischemiques Abandoned CA2533136A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US48919803P 2003-07-21 2003-07-21
US60/489,198 2003-07-21
US52705603P 2003-12-03 2003-12-03
US60/527,056 2003-12-03
PCT/US2004/023509 WO2005009540A1 (fr) 2003-07-21 2004-07-20 Traitement de lesions cerebrales perinatales hypoxiques-ischemiques

Publications (1)

Publication Number Publication Date
CA2533136A1 true CA2533136A1 (fr) 2005-02-03

Family

ID=34107790

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002533136A Abandoned CA2533136A1 (fr) 2003-07-21 2004-07-20 Traitement de lesions cerebrales perinatales hypoxiques-ischemiques

Country Status (4)

Country Link
EP (1) EP1648567A1 (fr)
CA (1) CA2533136A1 (fr)
NO (1) NO20060819L (fr)
WO (1) WO2005009540A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007131329A1 (fr) * 2006-05-12 2007-11-22 Vasogen Ireland Limited Traitement des troubles liés au dysfonctionnement du système ubiquitine-protéasome

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007131329A1 (fr) * 2006-05-12 2007-11-22 Vasogen Ireland Limited Traitement des troubles liés au dysfonctionnement du système ubiquitine-protéasome

Also Published As

Publication number Publication date
WO2005009540A1 (fr) 2005-02-03
NO20060819L (no) 2006-04-18
EP1648567A1 (fr) 2006-04-26

Similar Documents

Publication Publication Date Title
CA1320130C (fr) Methodes et compositions faisant appel a des antiinflammatoires non steroidiens encapsules dans des liposomes
AU638903B2 (en) Pulmonary administration of pharmaceutically active substances
KR970005171B1 (ko) 아라키돈산 대사물질 관련 리포좀 제조방법 및 그 제제
US20210378959A1 (en) Neuroprotective liposome compositions and methods for treatment of stroke
US20030175334A1 (en) Phospholipid bodies and use thereof in medical treatment
US20060008517A1 (en) Treatment of age-related memory impairment
PT726763E (pt) Metodos de tratamento utilizando formulacoes lipossomicas unilamelares de metabolitos de acido araquidonico
CA2533136A1 (fr) Traitement de lesions cerebrales perinatales hypoxiques-ischemiques
AU2006294756A1 (en) Treatment of inflammation and vascular abnormalities of the eye
US20060105032A1 (en) Multiple sclerosis treatment
US20030170223A1 (en) Pulmonary vasodilator surfactant compositions and method of use
US20050058698A1 (en) Pharmaceutically acceptable phosphate-glycerol carrying bodies and uses relating to Parkinson's Disease
WO2007085413A2 (fr) Traitement d'un accident ischémique transitoire
RU2213746C1 (ru) Компонент, обеспечивающий поверхностно-активные свойства композиций - аналогов препаратов для заместительной сурфактантной терапии легочных заболеваний
AU2003201569B2 (en) Pharmaceutically acceptable phosphate-glycerol carrying bodies
CN114668723A (zh) 一种含有局部麻醉药的脂质体及其制备方法
WO2007131329A1 (fr) Traitement des troubles liés au dysfonctionnement du système ubiquitine-protéasome
MXPA04007041A (es) Cuerpos de inclusion de fosfolipidos y uso de los mismos en tratamientos medicos.
US20080075764A1 (en) Pharmaceutically acceptable phosphate-glycerol carrying bodies
AU2003201568A1 (en) Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead